Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.

Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.

Item
http://www.wikidata.org/entity/Q38217723
Precision medicine for the treatment of severe pneumonia in intensive care.Relevant Cytokines in the Management of Community-Acquired Pneumonia.South African guideline for the management of community-acquired pneumonia in adults.Contribution of Progranulin to Protective Lung Immunity During Bacterial Pneumonia.Port d’Entrée for Respiratory Infections – Does the Influenza A Virus Pave the Way for Bacteria?Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia.Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia.Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.Intensive Care Society State of the Art 2017 Abstracts
P2860

Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.

Item
http://www.wikidata.org/entity/Q38217723
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.
@en
type
label
Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.
@en
prefLabel
Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.
@en
P1433
P1476
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Immunomodulatory adjuvant therapy in severe community-acquired pneumonia.
@en
P2860
P304
P31
P356
10.1586/17476348.2014.927736
P433
P478
P50
P577
P698
P921